scutellarin has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Liu, SB; Lu, L; Qi, JY; Wang, XS; Yang, F; Yang, LK; Yue, J | 1 |
| Bian, HT; Huang, JJ; Liang, L; Wang, GH; Wang, HL; Xiao, L | 1 |
2 other study(ies) available for scutellarin and Depression
| Article | Year |
|---|---|
Scutellarin alleviates depression-like behaviors induced by LPS in mice partially through inhibition of astrocyte-mediated neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Astrocytes; Depression; Glucuronates; Hippocampus; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases | 2021 |
Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Apigenin; Behavior, Animal; Caspase 1; Depression; Encephalitis; Glucuronates; Hippocampus; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Male; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Sprague-Dawley; Reactive Oxygen Species | 2020 |